Fri, 21 Jul 2017 12:00:00 EDT Body Composition and Adipose Tissue in HIV Conditions: HIV Lipodystrophy Syndrome; Growth Hormone Deficiency; Body Composition Intervention: Drug: Tesamorelin Sponsors: Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting - verified July 2017
Thu, 20 Jul 2017 12:00:00 EDT Heart Function in Patients Assessed for Sleep Apnoea Conditions: Heart Failure With Preserved Ejection Fraction; Sleep Disordered Breathing; Heart Failure With Normal Ejection Fraction; Obstructive Sleep Apnea; Central Sleep Apnea; Heart Failure Intervention: Sponsors: Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; ResMed Not yet recruiting - verified July 2017
Wed, 19 Jul 2017 12:00:00 EDT Effects of Dried Apple on Metabolic Responses Condition: Healthy Individual Interventions: Dietary Supplement: Dried apple; Dietary Supplement: Muffin Sponsor: San Diego State University Completed - verified July 2017
Wed, 19 Jul 2017 12:00:00 EDT Prospective Urban Rural Epidemiology Study Conditions: Cardiovascular Diseases; Risk Factor, Cardiovascular; Health Behavior; Environmental Exposure; Lung Diseases; Cancer; Injuries; Renal Disease; Communicable Disease Intervention: Sponsors: Population Health Research Institute; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario Recruiting - verified July 2017
Wed, 19 Jul 2017 12:00:00 EDT Fat Metabolites and Gut Hormones Conditions: Overweight and Obesity; Type 2 Diabetes; Bariatric Surgery; Gut Hormones; Dietary Fat Interventions: Dietary Supplement: C-8 dietary oil; Dietary Supplement: Tricaprylin; Dietary Supplement: Olive oil Sponsors: Hvidovre University Hospital; University of Copenhagen Recruiting - verified July 2017
Tue, 18 Jul 2017 12:00:00 EDT Simplification of CF-related Diabetes Screening at Home Conditions: Cystic Fibrosis; Cystic Fibrosis-related Diabetes Interventions: Diagnostic Test: Standard OGTT; Diagnostic Test: Home-based OGTT (Beverage); Diagnostic Test: Home-based OGTT (Candy) Sponsors: Institut de Recherches Cliniques de Montreal; Université de Montréal; Vertex Pharmaceuticals Incorporated Not yet recruiting - verified July 2017
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
FDA clears first neonatal magnetic resonance imaging device Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).
Thu, 20 Jul 2017 13:44:00 -0400 Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of the FDA Food Safety Modernization Act (FSMA) – to update and strengthen the FDA’s risk-based approach to the oversight of food safety.
Wed, 19 Jul 2017 09:46:00 -0400 FDA approves Vosevi for Hepatitis C The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
Tue, 18 Jul 2017 14:23:00 -0400 FDA approves new treatment to reduce the risk of breast cancer returning The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Nerlynx is indicated for adult patients who have been previously treated with a regimen that includes the drug trastuzumab.
Thu, 13 Jul 2017 10:30:00 -0400 FDA approves new treatment for sickle cell disease The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
Fri, 07 Jul 2017 11:16:00 -0400 Federal judge enters consent decree against Alabama compounder Medistat U.S. District Judge William H. Steele entered a consent decree of permanent injunction yesterday between the United States and Medistat RX LLC of Foley, Alabama, the company’s co-owners, Mark D. Acker and Timothy L. Fickling, and quality manager and pharmacist-in-charge V. Elaine Waller.
Thu, 06 Jul 2017 10:19:00 -0400 FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.
